Published in J Gastroenterol Hepatol on January 01, 2000
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol (2006) 1.53
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol (2012) 1.31
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol (2002) 1.30
Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut (2004) 1.26
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol (2011) 1.23
Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis (2008) 1.16
Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol (2009) 1.11
Probiotics and inflammatory bowel disease. J R Soc Med (2003) 1.10
Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration. J Clin Microbiol (2012) 1.04
Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol (2002) 1.01
Comparative evaluation of establishing a human gut microbial community within rodent models. Gut Microbes (2012) 0.94
High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Dig Dis Sci (2007) 0.93
Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol (2006) 0.92
Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci (2012) 0.92
Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut. Appl Environ Microbiol (2008) 0.86
Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats. Dig Dis Sci (2008) 0.86
Blueberry husks and probiotics attenuate colorectal inflammation and oncogenesis, and liver injuries in rats exposed to cycling DSS-treatment. PLoS One (2012) 0.84
Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics (2011) 0.83
Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut (2004) 0.83
Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterol (2014) 0.82
Abnormal expression of the peptide transporter PepT1 in the colon of massive bowel resection rat: a potential route for colonic mucosa damage by transport of fMLP. Dig Dis Sci (2006) 0.80
Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol (2011) 0.80
Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci Rep (2015) 0.80
New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome (2017) 0.79
Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments. Gastroenterol Res Pract (2011) 0.78
Regulation of epithelial cell functions by the intestinal milieu. J Gastroenterol (2002) 0.78
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy (2007) 4.52
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol (2007) 1.87
Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J Clin Oncol (2000) 1.84
Genome-wide profiling of promoter methylation in human. Oncogene (2006) 1.55
Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta (1998) 1.52
Primary gastric Burkitt's lymphoma presenting with c-myc gene rearrangement. J Gastroenterol (1998) 1.51
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer (1997) 1.49
Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. J Gastroenterol (2000) 1.47
Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors. J Gastroenterol (2000) 1.45
A novel IgA protease from Clostridium sp. capable of cleaving IgA1 and IgA2 A2m(1) but not IgA2 A2m(2) allotype paraproteins. J Immunol (1985) 1.38
Oxidized and reduced nicotinamide adenine dinucleotide phosphate levels of plants hardened and unhardened against chilling injury. Plant Physiol (1968) 1.37
Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol (1993) 1.34
Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol (2013) 1.28
cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun (1990) 1.27
Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology (2000) 1.19
The site of cleavage in human alpha chains of IgA1 and IgA2:A2m(1) allotype paraproteins by the clostridial IGA protease. Mol Immunol (1986) 1.18
Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. Blood (2000) 1.17
Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol (1998) 1.15
Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int J Mol Med (1999) 1.14
Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol (1999) 1.13
Laryngeal muscle activity during stuttering. J Speech Hear Res (1978) 1.13
Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology (1996) 1.11
Genetic and epigenetic alterations in carcinogenesis. Mutat Res (2000) 1.11
Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas (1997) 1.10
Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol (2000) 1.10
A selective medium for isolation and presumptive identification of the Bacteriodes fragilis group. Microbiol Immunol (1983) 1.09
Attractin/mahogany/zitter plays a critical role in myelination of the central nervous system. Proc Natl Acad Sci U S A (2001) 1.09
Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene (2011) 1.09
Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy. J Gastroenterol Hepatol (2000) 1.09
RUNX3 expression correlates with chief cell differentiation in human gastric cancers. Histol Histopathol (2009) 1.08
Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim Biophys Acta (2001) 1.08
Clostridium ramosum, an IgA protease-producing species and its ecology in the human intestinal tract. Microbiol Immunol (1985) 1.07
Severe anemia in a patient with isolated adrenocorticotropin deficiency. Intern Med (1996) 1.07
Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer (2000) 1.06
Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene (1991) 1.06
Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol (2000) 1.04
Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG. Microbiol Immunol (1987) 1.04
Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci U S A (1995) 1.04
Cloning of the rat agouti gene and identification of the rat nonagouti mutation. Mamm Genome (2001) 1.03
Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene (2011) 1.02
Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology (2005) 1.02
Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res (1995) 1.02
Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenet Genome Res (2006) 1.01
Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin Exp Immunol (2001) 1.01
Recurrence of cerebral aneurysm after initial neck clipping. Neurosurgery (1982) 1.00
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect. Jpn J Cancer Res (1997) 0.99
Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J Gastroenterol Hepatol (2001) 0.99
A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats. Clin Exp Immunol (1998) 0.98
Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene (2001) 0.98
An experimental study of the contraction properties of the laryngeal muscles in the cat. Ann Otol Rhinol Laryngol (1969) 0.98
Ulcerative colitis complicated by gastroduodenal lesions. J Gastroenterol (1996) 0.97
Biotyping of Propionibacterium acnes isolated from normal human facial skin. Appl Environ Microbiol (1979) 0.97
Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol (2002) 0.97
Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol (2001) 0.96
Genetic changes induced by heterocyclic amines. Mutat Res (1997) 0.96
Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. JPEN J Parenter Enteral Nutr (1999) 0.96
Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alphaC) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Cancer Lett (1997) 0.94
Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase-negative Staphylococcus on normal human skin. Can J Microbiol (1984) 0.94
Small intestinal perforation due to cytomegalovirus infection in patients with non-Hodgkin's lymphoma. Acta Haematol (1995) 0.94